Drug – bio-affecting and body treating compositions – Plant material or plant extract of undetermined constitution... – Containing or obtained from a bark
Reexamination Certificate
2008-05-27
2008-05-27
Tate, Christopher R. (Department: 1655)
Drug, bio-affecting and body treating compositions
Plant material or plant extract of undetermined constitution...
Containing or obtained from a bark
C424S779000, C424S725000
Reexamination Certificate
active
07378115
ABSTRACT:
The present invention relates to herbal compositions for the prevention or treatment of disorders of the urogenital system, e.g., urinary incontinence, enuresis (e.g., bed-wetting), benign prostatic hyperplasia, urinary calculi, cystitis, urinary tract infection, and overactive bladder. Specifically, the invention provides compositions that containC. nurvalaandE. arvenseand methods of use thereof.
REFERENCES:
patent: 5683991 (1997-11-01), Guggenbichler et al.
patent: 6277396 (2001-08-01), Dente
patent: 7025998 (2006-04-01), Senin et al.
patent: 2004/0147459 (2004-07-01), Oneal et al.
patent: 2004/0241260 (2004-12-01), Senin et al.
Castleman, M. The Healing Herbs—The Ultimate Guide to the Curative Power of Nature's Medicines. 1991. Rodale Press, Emmaus, PA, pp. 219-221.
The PDR for Herbal Medicines. 1998. Medical Economics Co., Montvaile, NJ. pp. 830-831.
Schauss et al. Faseb J. Mar. 2006. vol. 20, No. 5, Part 2, p. A990—Meeting Abstract. Biosis Abstract enclosed.
Anderson, K.E., New parmacologic targets for the treatment of the overactive bladder: an update, Urology. 63(3 Suppl 1):32-41., 3A: 32-41 (2004).
Appell, R.A. et al., Pharmacokinetics, metabolism, and saliva output during transdermal and extended-release oral oxybutynin administration in healthy subjects, Mayo Clinical Proc., 78:696-702. (2003).
Arya, L.A. et al., Dietary caffeine intake and the risk for detrusor instability: a case-control study, Obstet Gynecol. 96(1):85-9 (2000).
Laycock, J., Association for Continence Advice, UK Survey of Patients-National Care Audit 1998-99, Aust. Continence J.; 6(2): 15-23 (2000).
Battaglia, S., In: “The Complete Guide to Aromatherapy”, The Perfect Potion Pty Ltd, Virginia, Brisbane, Qld, Australia, pp. 110-113, 116, 150-151, 158-159, 182-183, 184-185, 187 (1995).
Bone K., “Clinical Applications of Ayurvedic and Chinese Herbs. Monographs for the western herbal practitioner”, Phyotherapy Press, Warwick, Qld. Australia, pp. 112-114 (1997).
Caddy, R., “Aromatherapy Essential Oils in Colour”, Amberwood Publishing Ltd, East Horsley, Surrey, England; p. 14 (1997).
Chidell, L., “Aromatherapy. A Definitive Guide to Essential Oils” Hodder and Stoughton Ltd, Kent, UK, 23-24, 80-81 (1992).
Cruz, F., Mechanisms involved in new therapies for overactive bladder, Urology. 63(3 Suppl 1):65-73. (2004).
Damian, P.K., “Aromatherapy Scent and Psyche”, Healing Arts Press, Rochester, Vermont, Canada, pp. 187-188 (1995).
Davis, P., “Aromatherapy An A-Z”, The C. W. Daniel Company, Essex, England, p. 194 (1998).
Deshpande P. J. et al.,Crataeva nurvalaHook and Forst (Varuna)—the Ayurvedic drug of choice in urinary disorders, Indian J. Med Res., 76(Suppl): 46-53(1982).
Geetha T. et al., Anti-inflammatory activity of lupeol and lupeol linoleate in rats. J Ethnopharmacol, 76(1):77-80 (2001).
Holmes, P., “The Energetics of Western Herbs”, Artemis Press, Boulder, Colorado, USA, pp. 567-569, 792 (1989).
Lakshmi V. et al., A new pentacyclic triterpene from the root bark ofCrateva nurvala. Planta Medica, 32: 214-216 (1977).
Lawless, J., “The Encyclopaedia of Essential Oils”, (1992) Element Books for Jacaranda Wiley, Ltd, Australia, pp. 76-77, 88-89, 135-136 (1992).
Nadkarni K. M. et al.,Crataeva religiosa, Indian Materia Medica. Bombay Popular Prakashan; British Herbal Pharmacopeia. Publ: British Herbal Medicine Association, pp. 387-388 (1983).
Nagao A. et al., Inhibition of xanthine oxidase by flavonoids, Biosci. Biotechnol. Biochem. 63(10): 1787-90 (1999).
Pathak A.S. et al., “Overactive Bladder: Drug therapy versus nerve stimulation”, Nat. Clin. Pract. Urol., 2(7):310-311 (2005).
Price, S., “Practical Aromatherapy”, Thorsons, Harper Collins Publishers, California, U.S., pp. 174-175 (1983).
Price, S., “The Aromatherapy Workbook”, Thorsons (Harper Collins), California, USA, p. 66-7 (1993).
Salvat A. et al., Screening of some plants from Northern Argentina for their antimicrobial activity. Lett. Appl. Microbiol., 32(5):293-7 (2001).
Sellar, W., “The Directory of Essential Oils”, Saffron Walden, The C. W. Daniel Company, Essex, England, 50-51, 106-107 (1992).
Sheppard-Hanger., “The Aromatherapy Practitioner Manual”, Aquarius Publishing, Willetton, Western Australia, p. 183 (1995).
Steels E. et al., Herbal essential oils for urinary incontinence, Austr. Continence J., 7(2):34-37 (2001).
Steels E. et al.,Crataeva equisetumreduce urinary incontinence symptoms, Austr. Continence J., 8(3): 46-50 (2002).
Stewart W.F. et al., Prevalence and burden of overactive bladder in the United States, World J. Urol. 20: 327-336, (2003).
Tisserand and Balacs, “Essential Oil Safety. A Guide for Health Care Professional”, Churchill Livingstone, U. K.; pp. 28-29, 31, 33-34 (1995).
Valnet, J., “Practice of Aromatherapy”, Saffron Walden, The C. W. Daniel Company, Essex, England, pp. 120-121 (1980).
Varalakshmi P. et al., Effect ofCrataeva nurvalain experimental urolithiasis, J. Ethnopharmacol., 28: 313-321 (1990).
Varalakshmi P. et al., Effect ofCrataeva nurvalaon the biochemistry of the small intestinal tract of normal and stone-forming rats, J. Ethnopharmacol. 31: 67-73 (1991).
International Search Report, PCT/IB2005/003370, Mailed Mar. 14, 2006.
Andersson, Karl-Erik, “Drug therapy for urinary incontinence,” Bailliére's Clinical Obstetrics and Gynaecology, vol. 14, No. 2, pp. 291-313, 2000 Harcourt Publishers, Ltd.
Grases, F., et al., Urolithiasis and Phytotherapy, International Urology and Nephrology 26 (5), pp. 507-511 (1994).
Owens, R. G., et al., Comparative Tolerability of Drug therapies Used to Treat Incontinence and Enuresis, Drug Safety Aug. 19, 1998 (2), 123-139, Adis International Limited.
Bryant, C. et al., A randomized trial of the effects of caffeine upon frequency, urgency and urge incontinence, Austr. Continence J., Abstracts from the 9thAnnual Scientific Meeting of the Continence Foundation of Australia, Hobert, Tasmania, 6(4):8 (2000).
Chevallier, A., “The Encyclopedia of Medicinal Plants”, (Horn V. and Weil, C., Eds.) Dorling Kindersley Ltd., London (1996).
D'Agostino, M. et al., Sterols fromEquisetum arvense. Boll. Soc. Ital. Biol. Sper., 60(12):2241-5 (1984).
Das P. K. et al., Anti-Inflammatory and Anti-Arthritic Activity ofCrataeva nurvalaBuch-Ham (Varuna), J. Res. Ind. Med., 9:49 (1974).
Geetha, T. et al., Anticomplement activity of triterpenes fromCrataeva nurvalastem bark in adjuvant arthritis in rats. Gen. Pharmacol., 32(4):495-7 (1999).
Karantanis, E. et al., “Electroacupuncture for refractory idiopathic detensor instability or sensory urgency”, Austr. Continence J., Abstracts from the 9thAnnual Scientific Meeting of the Continence Foundation of Australia, Hobert, Tasmania, 6(4):6-7 (2000).
Malini, M. M., et al., Effect of lupeol, a pentacyclic triterpene, on urinary enzymes in hyperoxaluric rats, Jpn J Med Sci Biol. 48(5-6): 211-20 (1995).
Peake, S. et al., “Part and parcel of being a woman”: female urinary incontinence and constructions of control, Med Anthropol. Q, 13(3):267-85 (1999).
Perez Gutierrez, R. M. et al., Diuretic activity of Mexican equisetum. J. Ethnopharmacol. 14(2-3):269-272 (1985).
Robinson, D. et al., Relationship Between Patient Reports of Urinary Incontinence Symptoms and Quality of Life Measures, Obstetrics and Gynecology, 92:2, 224-8 (1998).
Sullivan, J. et al., Pharmacological management of incontinence. Eur. Urol. 36 Suppl 1:89-95 (1999).
Tapp, A. J. S. et al., The treatment of detrusor instability in post-menopausal women with oxybutynin chloride: a double blind placebo controlled study, Br. J. Obstet. Gynaecol., 97(6):521-6 (1990).
Wada, Y. et al., Comparison of the effects of various anticholinergic drugs on human isolated urinary bladder, Arch. Int. Pharmacodyn. Ther., 330(1):76-89 (1995).
Wein, A.J., Pharmacological agents for the treatment of urinary incontinence due to overactive bladder, E
Biologic Health Solutions Pty Ltd.
Ewing James F.
Foley & Lardner LLP
Morency Michel
Tate Christopher R.
LandOfFree
Herbal compositions for the prevention or treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Herbal compositions for the prevention or treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Herbal compositions for the prevention or treatment of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2813556